Home › Endometrial Cancer › Michigan › Farmington Hills
Endometrial Cancer clinical trials in Farmington Hills, MI
4 studies for Endometrial Cancer are looking for participants at sites in and around Farmington Hills (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Weisberg Cancer Treatment Center, Farmington Hills
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Corewell Health Farmington Hills Hospital, Farmington Hills
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RecruitingPhase 1
- Karmanos Cancer Institute, Farmington Hills
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Oklahoma City, OK25 studies
- Chicago, IL25 studies
Other studies in Farmington Hills
- Non-Small Cell Lung Cancer13 studies
- Parkinson's Disease13 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Heart Failure9 studies
- Lung Cancer8 studies
- Prostate Cancer8 studies
- Alzheimer's Disease8 studies
- Bladder Cancer6 studies
- Multiple Sclerosis6 studies
- COPD6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.